Side-by-Side Comparison · 2026

GHRP-2 vs Tesamorelin

GHRP-2 vs Tesamorelin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

GHRP-2
Growth Hormone

GHRP-2 (Pralmorelin) is a synthetic hexapeptide growth hormone releasing peptide and one of the most potent first-generation GHRPs. It stimulates pituitary GH secretion via the ghrelin receptor (GHSR-1a) with greater potency than GHRP-6, while producing less appetite stimulation....

Calculate GHRP-2 dose →
Tesamorelin
Growth Hormone

Tesamorelin is an FDA-approved synthetic GHRH analog (Egrifta) modified with trans-3-hexenoic acid to resist DPP-IV enzymatic cleavage, doubling its effective half-life. It restores pulsatile GH secretion and preferentially reduces visceral adipose tissue. Approved in 2010 for HI...

Calculate Tesamorelin dose →
Key Parameters
Parameter GHRP-2 Tesamorelin
Category Growth Hormone Growth Hormone
Research Extensively Studied FDA Approved
Half-Life ~30–60 min ~26–38 min
Typical Dose 100–300 µg 1–2 mg
Frequency 1–3× daily Once daily
Route Subcutaneous Subcutaneous
FDA Status Not Approved (US) Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate GHRP-2 Calculate Tesamorelin
Frequently Asked Questions
What is the difference between GHRP-2 and Tesamorelin?
GHRP-2: GHRP-2 (Pralmorelin) is a synthetic hexapeptide growth hormone releasing peptide and one of the most potent first-generation GHRPs. It stimulates pituitary GH secretion via the ghrelin receptor (GHSR-... Tesamorelin: Tesamorelin is an FDA-approved synthetic GHRH analog (Egrifta) modified with trans-3-hexenoic acid to resist DPP-IV enzymatic cleavage, doubling its effective half-life. It restores pulsatile GH secre...
Which has a longer half-life, GHRP-2 or Tesamorelin?
GHRP-2 half-life: ~30–60 min. Tesamorelin half-life: ~26–38 min.
Can you stack GHRP-2 and Tesamorelin?
GHRP-2 and Tesamorelin are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.